Release Date: 18/09/17 16:12 Summary: Appendix 3B - Exercise of options Price Sensitive: No Download Document 633.84KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%